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Abstract
Background: Mitochondria are central to the metabolism of cells and participate in many regulatory and signaling events.
They are looked upon as dynamic tubular networks. We showed recently that the Carboxy-Terminal Modulator Protein
(CTMP) is a mitochondrial protein that may be released into the cytosol under apoptotic conditions.
Methodology/Principal Findings: Here we report an unexpected function of CTMP in mitochondrial homeostasis. In this
study, both full length CTMP, and a CTMP mutant refractory to N-terminal cleavage and leading to an immature protein
promote clustering of spherical mitochondria, suggesting a role for CTMP in the fission process. Indeed, cellular depletion of
CTMP led to accumulation of swollen and interconnected mitochondria, without affecting the mitochondrial fusion process.
Importantly, in vivo results support the relevance of these findings, as mitochondria from livers of adult CTMP knockout
mice had a similar phenotype to cells depleted of CTMP.
Conclusions/Significance: Together, these results lead us to propose that CTMP has a major function in mitochondrial
dynamics and could be involved in the regulation of mitochondrial functions.
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Introduction
Mitochondria are the site of metabolic and survival functions
important in organism development, immunity, aging and
pathogenesis [1–3]. It is becoming clear that these crucial
functions within the cell rely on the integrity of the complex
double-membrane mitochondria structure that compartmentalizes
vastly different enzymatic activities, mainly involved in oxidative
phosphorylation [4], the TCA cycle, gluconeogenesis [5], death
signal integration [6,7] and the amplification and transmission of
mitochondrial DNA (mtDNA) [8]. Mitochondria within healthy
cells are often organized into a dynamic tubular and branched
network that undergoes intensive remodeling in response to
various stimuli related to cell death [9–11] as well as metabolic and
developmental processes [12]. The anti-apoptotic Bcl-2 family
member Bcl-xL and the antagonist BH3 only proteins Bak/Bax
were shown to regulate mitochondrial shape in healthy cells as well
as in cells undergoing apoptosis [13,14]. Thus, the increasing
reports of the involvement of signaling proteins in the modulation
of mitochondria expose a link between mitochondrial function and
dynamics in the regulation of metabolism, cell death, neurotrans-
mission, cell cycle control and development [15].
Studies with yeast led to the identification of the conserved
mammalian ‘‘mitochondria-shaping’’ proteins. Profusion proteins,
such as the dynamin-related protein mitofusins 1 and 2 (Mfn1 and
Mfn2), are integral components of the outer mitochondrial
membrane (OMM), essential to mitochondria tethering and fusion
[16,17]. These proteins act together with the optic atrophy protein
1 (OPA1), and an inner mitochondrial membrane (IMM) located
dynamin-like GTPase mutated in heritable optical atrophy [18].
Conversely, the dynamin-related protein 1 (Drp1/DNM1) is a
cytosolic protein, recruitment of which to the OMM by the
anchored fission 1 protein (Fis1p/FIS1) adaptor initiates and
controls the fission and distribution of mitochondria in cells [19].
Previously, we identified the Carboxy-Terminal Modulator
Protein (CTMP) in a two-hybrid search for PKB/Akt binding
partners [20]. CTMP has been shown to inhibit PKB/Akt
activation at the plasma membrane in response to various stimuli
and also to have tumor suppressor-like functions. This notion was
strengthened by the observation that primary glioblastomas exhibit
downregulation of CTMP mRNA levels due to promoter
hypermethylation [21]. We recently reported the mitochondrial
localization of endogenous and exogenous CTMP [22]. CTMP
exhibits a dual sub-mitochondrial localization as a membrane-
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membrane space; it was released from the mitochondria into the
cytosol early during apoptosis. CTMP overexpression was associ-
ated with an increase in mitochondrial membrane depolarization,
caspase-3 and polyADP-ribose polymerase (PARP) cleavage. In
contrast, CTMP knockdown resulted in a marked reduction in the
loss of mitochondrial membrane potential as well as a decrease in
caspase-3 and PARP activation. Mutant CTMP retained in the
mitochondria lost its capacity to sensitize cells to apoptosis. Thus,
proper maturation of CTMP appears essential for its pro-apoptotic
function. Finally, we demonstrated that CTMP delayed PKB/Akt
phosphorylation following cell death induction, suggesting that
CTMP regulates apoptosis via inhibition of PKB/Akt.
Here we show that compromising Carboxy-Terminal Modula-
tor Protein (CTMP) integrity by preventing its N-terminal
cleavage by point mutation or by a knockdown approach affected
mitochondrial network organization in cells. CTMP depletion did
not affect mitochondria intercomplementation but enhanced the
interconnected network, suggesting that CTMP positively influ-
ences the mitochondrial fission process, arguing for a potential role
of CTMP in regulating mitochondrial functions.
Results
A defect in N terminal cleavage of CTMP expression leads
to swollen mitochondria
HeLa cells transfected with full-length CTMP GFP-tagged
expressed CTMP in the mitochondria (Fig. 1A). Cells expressing
high levels of CTMP induced a change in mitochondrial
phenotype in some cells, with more rounded shaped mitochondria
evident in these cells (Fig. 1A, lower panels). CTMP contains a
conserved N-terminal cleavable mitochondrial localization signal
(MLS) and is located almost exclusively in mammalian cell
mitochondria. CTMP has been found to be strongly associated
with the inner mitochondrial membrane or free in the inter-
membrane space [22]. Most MLS are cleaved by a mitochondrial
processing peptidase (MPP) that recognizes a special sequence
comprising a positive arginine residue at position 22 and/or 210
from the cleavage site [23,24]. The CTMP sequence displays a
highly probable R-2 site at serine 35, surrounded by a
hydrophobic residue at +1 and a serine at +2. A CTMP mutant
(m5) in which R34, F36 and S37/38 have been mutated to alanine
(Fig. 1B) leads to the expression of a non-mature CTMP that still
bears the MLS and that cannot be released to the cytosol after
apoptosis induction [22]. Similar to full-length CTMP, we
observed that over-expression of a CTMP mutant m5 refractory
to N-terminal cleavage promoted the formation of rounded, ball-
shaped mitochondria, compared with the tubular structures
observed in cells transfected with the wild-type protein (Fig. 1C),
or untransfected cells (Fig. S1). It should be noted that CTMP
subcellular distribution was not affected by its over-expression.
These data led us to hypothesize that CTMP may regulate
mitochondrial biogenesis.
Loss of CTMP affects mitochondria morphology
Mitochondrial dynamics is regulated by continuous fusion and
fission events. Previous reports indicate that cellular depletion of
pro-fission proteins, such as Drp1 or the pro-fusion proteins Mfn-1
and -2, leads to the formation of an interconnected or a
fragmented mitochondrial network, respectively [16,17,25]. In
contrast, overexpression of Mfn-1 or Mfn-2 produces an
imbalance in mitochondrial dynamics in a dose-dependent
manner and subsequently the perinuclear clustering of the entire
mitochondrial network. The putative involvement of CTMP in
mitochondrial network rearrangement was further investigated by
siRNA-mediated depletion of CTMP in HeLa cells. Efficient and
reproducible knockdown of CTMP protein was achieved in cells
transfected with two independent CTMP siRNAs (Si#1 and
Si#2) compared with the mock siRNA (Si-cont) (Fig. 2A).
Cells expressing RFP-labeled mitochondria (mt-RFP) were used
to monitor the impact of CTMP depletion on mitochondrial
network organization. In these cells, loss of CTMP protein led to a
twofold decrease in tubular mitochondrial subpopulation (type II)
compared with control cells (Fig. 2B). Although most CTMP-
negative cells displayed filamentous mitochondria, detailed
confocal examination showed the accumulation of a mixed
network of interconnected swollen and thick mitochondria
(Fig. 2C; type I Si-CTMP#1 and #2) compared with the Si-
cont transfected cells (Fig. 2C; type I Si-cont). To further explore
the correlation between CTMP protein depletion and mitochon-
dria remodeling at the single-cell level, tetracycline repressor-
expressing HeLa cells were stably transfected with sh-RNA
specifically targeting CTMP (CTMP-Sh; targeting a sequence
distinct from the previously described Si#1 and Si#2) or control
sh-RNA (Fig. 3A). We confirmed that organization of the
mitochondria network in CTMP-depleted cells was similar to
the previously observed network (Fig. 3B). The population of cells
exhibiting a swollen interconnected mitochondrial network was
evident 3 days after tetracycline treatment (Fig. 3C). Combined,
these results strongly suggest that the modulation of CTMP
protein levels and maturation affect mitochondrial shape.
CTMP depletion does not impair mitochondrial fusion
To determine whether loss of CTMP function affected
mitochondrial fusion or fission, an intermitochondrial comple-
mentation assay was carried out using CTMP-depleted cells
[26,27]. Forty-eight hours after transfection with CTMP siRNA
(Si#1, Si#2) or the siRNA control (Si-cont), HeLa cells carrying
labeled mitochondria (mt-GFP and mt-RFP) were mixed in equal
proportions and fused by addition of PEG 1500. Heterokaryons
were fixed at the indicated times and mitochondrial fusion kinetics
assessed by examination using confocal microscopy of the yellow
fluorescence resulting from the mixing of matrix-targeted GFP and
RFP mitochondria (Fig. 4A). CTMP-depleted cells completed
mitochondria fusion with kinetics comparable to those of control
cells (Fig. 4B). These data suggested that CTMP is not critical for
the mitochondrial fusion process and further supports the
conclusion that the effects of CTMP depletion result from an
altered fission process.
CTMP deletion reveals an extensively interconnected
mitochondrial network in mouse liver
We next examined the effect of CTMP deletion on mitochon-
drial shape at the whole organism level. CTMP knockout mice
generated in our lab were viable and fertile and showed no obvious
phenotype. A summary of the knockout strategy is given in Fig. 5A,
B. We further validated the mitochondrial localization of CTMP
in mouse tissue. Immunodetection of CTMP protein in wild-type
(WT), heterozygous and homozygous knockout mice showed a
correlation between loss of CTMP protein and CTMP allele
disruption (data not shown). Mitochondria from WT and CTMP
knockout (2/2) mouse livers were purified by differential and
density gradient centrifugation (Fig. 5C, left panel). Immunoblot
analysis of the collected fractions demonstrated the purity of the
mitochondria (cytochrome c and mHsp70) and the absence of
cytosolic contaminants (actin). As expected, CTMP immunodetec-
tion showed that mouse CTMP protein co-purified with the
mitochondrial fraction, as confirmed by the loss of a signal in
CTMP and Mitochondria Dynamic
PLoS ONE | www.plosone.org 2 May 2009 | Volume 4 | Issue 5 | e5471Figure 1. Interfering with CTMP maturation leads to swollen mitochondria. (A) Full length human CTMP tagged with GFP was transfected
into HeLa cells at low (upper panels) or high (lower panels) levels of expression. Mitochondria were visualized with Mitotracker Red. Merged
fluorescence indicates CTMP-GFP expression in mitochondria. The round appearance of mitochondria is visible in cells with high levels of CTMP
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copy of thin liver sections from WT and CTMP knockout mice
revealed a correlation between the ablation of CTMP and the
appearance of elongated mitochondria (Fig. 5D lower panels),
compared with the round and compact mitochondria in the liver
of wild-type animals (Fig. 5D upper panels). Accordingly,
mitochondria were found to be elongated in hepatocytes isolated
from CTMP knockout mice (2/2), compared with round and
compact mitochondria observed in hepatocytes of wild-type
animals (Fig. S2). Interestingly, loss of CTMP did not interfere
with mitochondria biogenesis, since the number of mitochondrial
DNA copies measured by real time PCR was the same in brown
adipose tissue (Fig. S3A) and in hepatocytes (Fig. S3B) from both
WT and knockout animals (2/2). Taken together, these results
demonstrate that depletion of CTMP protein impairs mitochon-
dria shape and structure both in vitro and in vivo.
Discussion
We provide here the first evidence that CTMP, previously
reported to be an inhibitor of PKB/Akt [20], is involved in the
modulation of mitochondria homeostasis. We have shown that
interference with CTMP expression and/or protein maturation
critically affected mitochondria morphology. Loss of cellular
CTMP expression led to the establishment of an interconnected
mitochondrial network in 40% of cells without affecting cell
viability (data not shown). Furthermore, CTMP knockdown
appeared to have a second long-term effect leading to the
accumulation of swollen mitochondria, either interconnected or
tubular. Importantly, such a phenotype has been reported
previously in cells depleted for proteins involved in the regulation
of the mitochondrial fission process, such as Drp1 or the recently
identified Drp1-binding protein MARCH-5 [14,28]. Mitochon-
dria from CTMP knockdown cells efficiently fuse in vitro,
suggesting that the observed phenotype, presumably caused by
imbalanced fusion/fission, does not result from a dysfunction in
mitochondrial fusion. Indeed, we provide evidence that CTMP
function in mitochondria is tightly linked to its submitochondrial
distribution, where it is found in both soluble and membrane-
bound mitochondrial fractions [22]. Expression of a non-cleavable
mutant of CTMP (refractory to mitochondrial membrane
peptidase cleavage) in HeLa cells promoted dissociation of the
mitochondrial network into individual round-shaped, dilated
mitochondria.
We recently reported that CTMP is released early from
mitochondria into the cytosol upon apoptosis and we demonstrat-
Figure 2. Loss of CTMP affects mitochondria morphology. (A) Immunoblot detection of CTMP using 75 mg of protein lysates extracted from
Hela cells 48 h after transfection with control SiRNA (cont) or CTMP SiRNA#1o r#2. (B) Representative confocal picture of mitochondria shape in
HeLa cells expressing mt-RFP and treated as in (A). (C) Morphological analysis of mitochondria shape in HeLa cells treated as in (A). For each
experiment, at least 200 cells were counted in three distinct fields. Data are means6SEM, n=2. The differences in mean values are statistically
significant (Si cont compared to Si-CTMP#1 and Si-CTMP#2) as determined by 1-way ANOVA; * P#0.05, ** P#0.001.
doi:10.1371/journal.pone.0005471.g002
expression (lower panels). (B) Amino acid sequence of the R-2 predicted MPP cleavage site (indicated by the arrow) in human CTMP and a CTMP
mutant (m5) in which R34, F36 and S37/38 have been mutated to alanine. (C) Twenty-four hours after transfection with CTMP-IRES-GFP or the m5
point mutant, HeLa cells were fixed and stained for CTMP and mitochondria as indicated. A detail of the squared area is shown in the right panel.
Representative confocal pictures of three independent experiments are shown.
doi:10.1371/journal.pone.0005471.g001
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mitochondrial membrane depolarization and the activation of
apoptotic markers such as caspase-3 and PARP. Furthermore, we
observed that CTMP depletion or a defect in CTMP maturation
leads to inhibition of apoptosis. We suggested that CTMP
regulates apoptosis via PKB/Akt inhibition since we detected a
delay in PKB/Akt phosphorylation in cells overexpressing CTMP
in which apoptosis was induced [22]. Similarly, other recent
reports suggest that the regulation of OPA1 relies on the activity of
a presenilin-associated rhomboid-like protein (PARL), a protease
that regulates OPA1 release into the inner mitochondrial space
[29]. Furthermore, Cipolat et al. [30] suggested that the loss of this
soluble OPA1 species in PARL2/2 cells is responsible for their
extreme sensitivity to apoptotic stimuli. They further proposed a
complex mechanism by which both soluble and inner mitochon-
drial membrane-anchored OPA1 regulates the tight closure of the
mitochondria cristae, preventing massive release of cytochrome c
into the inter-mitochondrial space.
Taken together, these observations lead us to hypothesize that
accumulation of a premature form of CTMP in the inner
mitochondrial membrane (due to inhibition of mitochondrial
membrane peptidase cleavage) may be responsible for the
observed mitochondrial phenotype. Moreover, in vitro character-
ization of the molecular mechanisms regulating inner mitochon-
drial membrane dynamics are as yet poorly understood.
Surprisingly, a subtle abnormal mitochondrial phenotype in the
Figure 3. CTMP expression affects mitochondrial network organization. (A) Confocal microscopy of CTMP expression in tetracycline
inducible HeLa clones stably expressing pTer plasmid coding for a control short hairpin (Sh-cont) or a short hairpin directed against CTMP (Sh#1 and
Sh#2). Cells were visualized by immunofluorescence after 5 days culture in the presence or absence of tetracycline (2 mg/mL), together with the
MitoTracker Red. (B) Representative confocal pictures of mitochondrial shape in tetracycline-inducible HeLa clones cultured 5 days in the presenceo f
tetracycline. Mitochondria were visualized with MitoTracker Red. (C) Morphological analysis of mitochondria shape in HeLa Tet-on clones treated asi n
(A) for 3, 4 or 5 days. For each experiment, at least 200 cells were counted in three distinct fields. Data are means6SEM, n=2. The differences in mean
values are statistically significant (Sh#2 minus tetracycline compared to Sh#2 plus tetracycline) as determined by 1-way ANOVA; ** P#0.001.
doi:10.1371/journal.pone.0005471.g003
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PLoS ONE | www.plosone.org 5 May 2009 | Volume 4 | Issue 5 | e5471Figure 4. CTMP is not required for mitochondrial fusion. (A) Hela cells expressing mt-RFP and mt-GFP transfected with either siRNA#1 and
#2 against CTMP or the siRNA control were fused in 50% PEG1500 for 60 s, washed and fixed at different times (4, 6 and 8 h). (B) Time-course of
mitochondrial fusion in HeLa cells treated as in (A). Mitochondrial fusion was measured from 30 randomly selected polykaryons and classified as
described in (A), n=2.
doi:10.1371/journal.pone.0005471.g004
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PLoS ONE | www.plosone.org 7 May 2009 | Volume 4 | Issue 5 | e5471brain tissue of PKB/Akt knockout mice has been reported recently
[31]. These animals display fewer and larger mitochondrial
structures, and the authors suggest that PKB/Akt plays a
significant role in mitochondrial biogenesis. In addition, PKB/
Akt has been shown to translocate to the outer mitochondrial
membrane, following plasma membrane activation [32–34].
Although the biological significance of the translocation of active
PKB/Akt to the mitochondria is not yet clear, it has been reported
to be cell-type and stimulus-specific [35,36]. Thus, CTMP may
modulate PKB/Akt activity in a specific subcellular compartment,
e.g. the mitochondria or the cytosol, depending on the nature of
the stimulus (survival or apoptosis). Further investigation is needed
to integrate the direct and/or indirect modulation of PKB/Akt
activity in this model and more experiments will be required to
address the biological activity of CTMP.
Striking similarities exist between the mitochondria network
rearrangement observed in CTMP knockdown cells and those
already reported in cells knocked down for the Drp1 fission protein
or cells missing a functional OPA1 protein [14,29]. Nonetheless,
the loss of electron absorbance observed in CTMP knockout mice
liver mitochondria further supports the involvement of CTMP in
the maintenance of inner mitochondrial membrane integrity.
Thus, the phenotype observed following CTMP depletion with
respect to mitochondrial network rearrangements is less penetrant
than those already reported for the key mitochondria-shaping
proteins. Moreover, CTMP protein depletion did not affect HeLa
cell growth or mitochondrial transmembrane potential measured
in vitro (data not shown). Most interestingly, it has been shown that
CTMP interacts with LETM1, another mitochondrial protein
involved in mitochondrial morphology [37]. LETM1 is located in
the inner membrane of mitochondria and oligomerized in higher
molecular weight complexes [38]. LETM1 has been found to be
deleted in Wolf-Hirschorn syndrome (WHS), a complex congenital
syndrome characterized by microcephaly, growth and mental
retardation, seizures, epilepsy and other associated symptoms
[39,40]. LETM1 is considered as playing a major role in the
pathogenesis of seizures. The function of LETM1 in apoptosis,
mitochondrial homeostasis and mitochondrial dynamics is well
documented, although the different reports drew different
conclusions [37,38,41]. Thus, it will be very exciting to further
investigate the interplay between CTMP and LETM1 in
regulating mitochondrial dynamics and functions in future studies.
In particular, it would be of interest to explore the phenotype of
CTMP knockout mice in the context of Wolf-Hirschorn
syndrome.
It is plausible that CTMP mediates its effect by modulating the
activity of the key regulators of mitochondrial dynamics and
further experiments should address the biological mechanism by
which CTMP regulates mitochondrial functions. We have
demonstrated already that CTMP exhibits a dual submitochon-
drial localization. Therefore, the tight association between CTMP
protein integrity and maintenance of mitochondria shape observed
in this study provides a novel opportunity to investigate the
mitochondrial function of CTMP in metabolic regulation.
Materials and Methods
Cloning and plasmids construction
All CTMP untagged plasmids used in this study were constructed
following PCR amplification of hCTMP cDNA [20] and inserted
into the BamHI and EcoRI sites of the pcDNA4-IRES-GFP plasmid
[42]. CTMP point mutant (m5) was generated by site-directed
mutagenesis. To C-terminally tag the CTMP protein, the
pcDNA3.1-Myc-RFP plasmid was constructed by subcloning the
mRFP1 (monomeric Red Fluorescent Protein 1) cDNA [43] into the
KpnIa n dEcorV sites of the hygromycin resistant vector pcDNA3.1-
Myc. The following sequences encoded the CTMP-SiRNA#15 9-
UCGUCAUGACUGCCAAUCU-39 59- AGAUUGGCAGUCA-
UGACGA-39 and CTMP Si-RNA#25 9-CCCAUUUUCUUGA-
CCCAAA-39,5 9- UUUGGGUCAAG AAAAUGGG-39 used in this
study. The control SiRNAs were directed against the fluorescein
protein 59-UUCUCCGAACGUGUCACGU-39 and 59-ACGUGA-
CACGUUCGGAGAA-39(Quiagen).To stablyinduce expressionof
short hairpins in cells, the CTMP-specific tandem sequences 59-
GATCCCAAGACCCTATACTCAGA GGCGTTCAAGAGAC-
GCCTCTGAGTAGGGTCTTTTTGGAAA-39 and 59-A G C T -
TTT CCAAAAAGACCCTACTCAGAGGCGTCTCTTGAAC-
GCCTCTGAGT ATGGG TCGG-39 were cloned in the BglII/
HindIII sites of pTer vector [44]. The pTer control construct (cont-
Sh) used was directed against luciferase as previously described [45]




CTGG39. All construct sequences were confirmed using an ABI
PRISM 3700 DNA Analyzer (Applied Biosystems).
Antibodies
CTMP monoclonal antibodies were generated by repeated
immunization of BALB/c mice with 50–100 mg of purified full-
length His-CTMP protein (produced in E. coli), using Stimune
(Prionics AG, Schlieren Switzerland) as an adjuvant. Two months
after the priming injection, spleenic lymphocytes cells were fused
with P3AG8.653 myelanoma cell line (ATCC) and cultured
according to standard procedures. After ELISA screening of
hybridomas clone supernatants, epitope mapping was carried out
for the clone used in this study (52F11) using the GST-CTMP
deletion mutant and synthetic polypeptides. The monoclonal anti-
CTMP antibody characterized is IgG1. Anti-a-tubulin (YL 1/2)
antibody was used as hybridoma supernatants. The commercial
mouse anti-mHsp70 (JG1) was from Affinity BioReagents, mouse
anti-cytochrome c was from R&D System and rat a-actin was
from Santa Cruz Biotechnology.
Transient and stable transfections
HeLa cells were grown in Dulbecco’s Medium (Gibco)
supplemented with 10% fetal calf serum. HeLa cell lines stably
expressing the tetraycline repressor (HeLa Tet-on) and/or
mitochondria-labeled cells (mt-GFP, mt-RFP) were cultured in
Figure 5. The mitochondrial network is extensively interconnected in CTMP knockout mice liver. (A) Summary of the knockout strategy
used to generate CTMP knockout mice. (B) Genotyping of CTMP +/+ (wild-type), +/2 (heterozygous) and 2/2 (knockout) mice. Genomic DNA was
digested using Spe1 and probed using a CTMP cDNA fragment. A wild-type band (9 kb, lower band) and a CTMP knockout band (14 kb, upper band)
are indicated. (C) Summary of the mitochondria purification strategy outlined in Materials and Methods (left panel). Percoll gradient-isolated liver
mitochondria from wild-type (WT) or CTMP knockout (2/2) mice were separated by SDS-PAGE and immunoblotted for a-actin, mHsp70, cytochrome
c and CTMP (right panel). (D) Representative electron micrographs of liver mitochondria ultrastructure in (top) wild-type and (bottom) CTMP
knockout mice. Arrows indicate normal liver mitochondria (top) and elongated mitochondria (bottom). Representative images of mitochondria shape
from different experiments (blind) are shown at different magnifications (611,000, 614,000, 628,000).
doi:10.1371/journal.pone.0005471.g005
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(Sigma), respectively. For transfection, cells were plated in 6-well
plates or 10-cm dishes and transfected the following day at 60%
confluence using Lipofectamine 2000 following the manufacturer’s
instruction (Invitrogen). Small inhibitory RNA delivery was
achieved with Oligofectamine (Invitrogen). Stable clones express-
ing CTMP short hairpins or negative controls were selected 48 h
after transfection by addition of 0.8 mg/mL Zeocin and positive
clones were further maintained in 0.4 mg/mL Zeocin.
Protein extraction and mitochondria isolation
For whole cell extracts, cells were washed in 16 PBS and
resuspended in lysis buffer (50 mM Tris [pH 7.4], 150 mM
NaCl, 10% glycerol, 0.5% NP40, 0.5 mM Na-orthovanadate,
50 mM NaF, 80 mM b-glycerophosphate, 10 mM Na-pyro-
phosphate, 1 mM dithiothreitol, 1 mM EGTA, 10 mg leupep-
tin/ml and 10 mg aprotinin/ml). Mitochondria isolation was
carried out as previously described [41]. Briefly, cells were
washed twice in 100 mM sucrose, 1 mM ethylene glycol-bis(b-
aminoethyl ether)-tetraacetic acid (EGTA), 20 mM 3-(N-mor-
pholino) propanesulfonic acid (MOPS), pH 7.4 and 1 mg/mL
BSA. The pellet was resuspended in the same buffer solution
supplemented with 10 mM triethanolamine, 5% (v/v) Percoll,
0.1 mg/mL digitonin for 3 min at 4uC and homogenized with a
Potter homogenizer (10 strokes, 1’000 rpm) before being diluted
1/5 in 300 mM sucrose, 1 mM EGTA, 20 mM MOPS, pH 7.4
and 1 mg/mL BSA, and centrifuged at 2’500 g for 5 min at
4uC. The supernatant containing mitochondria was collected
and centrifuged at 10’000 g for 10 min at 4uC to collect
mitochondria as a pellet. Isolated mitochondria were washed
twice in the same conditions before being resuspended and
further processed.
Western-blotting
For Western blot analysis, protein lysates were prepared by
homogenization of various organs in lysis buffer (50 mM Tris-
HCl, pH 8.0, 120 mM NaCl, 1% NP-40, 40 mM b-glycerophos-
phate, 10% glycerol, 4 mM leupeptin, 0.05 mM phenylmethylsul-
fonyl fluoride, 1 mM benzamidine, 50 mM NaF, 1 mM Na3VO4,
5 mM EDTA, 1 mM Microcystin LR). Homogenates were
centrifuged twice (13’000 rpm for 10 min at 4uC) to remove cell
debris. Protein concentrations were determined using the Bradford
assay. Proteins were separated by 12% or 10% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and then transferred to
Immobilon-P polyvinylidene difluoride membranes (Millipore).
Immunostaining
For immunostaining, cells were grown on coverslips for 24 h
following transfection with different plasmids or siRNAs. Where
mitochondria were visualized by MitoTracker Red, cells were
treated with 300 nM MitoTracker Red CMXRos for 15 min
before being washed in PBS and fixed in 3% paraformaldehyde/
2% sucrose. Cells were further permeabilized using 0.2% Triton
6100 (3 min at room temperature) before being washed in PBS
and incubated together with an appropriate dilution of the
primary antibody for 1 h at room temperature in 1% BSA/1%
goat serum. This was followed by incubation with secondary
antibodies at 1:100 for 45 min at room temperature. After a final
washing, coverslips were mounted in Vectashield medium (Vector
lab) and visualized on a laser scanning microscope (Olympus
FV500). Confocal images were processed using the Imaris
program (Bitplane AG, Zu ¨rich, Switzerland) and Photoshop 6.0
(Adobe System Inc).
Mitochondria intercomplementation
HeLa cells carrying different fluorescent mitochondria (mt-RFP
or mt-GFP) were mixed 1/1 and plated on coverslips 24 h after
transfection. Mt-GFP HeLa cells were pre-treated for 20 h with
1 mM trichostatin to increase GFP expression levels. After washes
in FCS-free DMEM, droplets of 50% PEG 1500 were added
directly to cells and aspirated after 45–60 s. After several washes,
cells were collected and fixed at the indicated times and processed
for immunofluorescence. Heterokaryons were visualized by DNA
staining of the nucleus (To-Pro-3 iodide) and/or a-tubulin
staining.
Generation of CTMP knockout mice
For the generation of CTMP mutant mice, a mouse genomic
DNA fragment containing exons 2 and 3 was cloned into the
pBluescript vector and a Not1 site was generated in exon 2. A
,5-kb IRES-lacZ-Neo cassette was inserted into the NotI site,
which introduced a translational frame shift. The targeting
vector was linearized and electroporated into 129/Ola ES cells.
ES cell clones were screened by Southern blotting. DNA was
digested with SpeI and probed with an external probe. An
internal probe was then used on KpnI-digested DNA for further
characterization of ES cell clones that were positive for
homologous recombination. Correctly targeted ES cells were
used to generate chimeras. Male chimeras were mated with
wild-type C57BL/6 females to obtain CTMP+/2 mice, which
were intercrossed to produce CTMP homozygous mutants.
Progeny were genotyped for the presence of a targeted allele by
multiplex PCR.
Liver mitochondria isolation
All steps were carried out at 4uC. Mice were housed and
terminated according to Swiss legislation. Following termination,
freshly dissected liver tissues were immersed and extracted in MSH
buffer (pH 7,3) (5 mM HEPES, 70 mM sucrose, 210 mM manni-
tol, supplemented with 1 mM EDTA), before homogenization in a
glass homogenizer (at 500 rpm) in MSH Buffer (supplemented with
anti-proteases inhibitors) and centrifugation for 10 min at 800 g.
The fat coat was removed after centrifugation (10,000 g for 10 min
at 4uC) and the pellet was manually resuspended in 80 ml of
mitochondrial isolation buffer (MSH buffer: 36 ml/ml aprotinin,
5 ml/ml PMSF, 1 ml/ml leupeptin). A crude mitochondrial pellet
was isolated by differential centrifugation (3,000 g, 10,000 g and
9,000 g) before being layered on top of a 20-mL Percoll solution
(39.3 ml of Percoll, 73.5 ml of 10 mM HEPES, and 13.2 ml of
2.5 M sucrose) and centrifuged at 26,000 rpm for 45 min at 4uC. A
pure mitochondria layer was collected below the peroxisome layer
and washed twice in mitochondrial isolation buffer before being
submitted to protein quantification.
Transmission electron microscopy
Samples werecollected from the sameregions of liver(leftlobe and
median lobe neighboring the gallbladder) for both wild-type [2
females (27,5 and 42 weeks old) and 1 male (42 weeks old)] and
CTMP knockout mice [2 females (27,5 and 42 weeks old) and 1 male
(42 weeks old)] and immediately fixed for 1 h in 3% paraformalde-
hyde and 0.5% glutaraldehyde in PBS puffer (pH 7.4), washed twice
in PBS and post-fixed for 1 h in 1% osmium tetroxide (OSO4). After
dehydration with a graded ethanol series (50–100%) and infiltration
in 100% acetone, samples were embedded using an Epoxy-
Embedding kit (Epon, FLUKA) for 24 h at 60uC. Thin sections
(60–70nm) were obtained on Ultracut (Reichert-Jung) and analyzed
on a TEM Moragni 268D (Philips) at 80 kV.
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